US Patent Issued to Fred Hutchinson Cancer Research Center, The Regents of the University of California on March 25 for "Chelating platform for delivery of radionuclides" (Washington, California Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,325, issued on March 25, was assigned to Fred Hutchinson Cancer Research Center (Seattle) and The Regents of the University of California (Oakland, Calif.).

"Chelating platform for delivery of radionuclides" was invented by Roland K. Strong (Seattle), Peter Rupert (Seattle), Rebecca J. Abergel (Berkeley, Calif.), Ilya Captain (Moraga, Calif.) and Gauthier J P Deblonde (Berkeley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Siderocalin-metal chelator combinations that bind metallic radioisotopes used in nuclear medicine with high affinity are described. The high affinity siderocalin-metal chelator combinations include a number of chelator b...